These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17125648)

  • 1. [Something for something--physicians, drug industry and general welfare].
    Bro F; Olesen F
    Ugeskr Laeger; 2006 Nov; 168(46):3985. PubMed ID: 17125648
    [No Abstract]   [Full Text] [Related]  

  • 2. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 3. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of data, authorship, and responsibility for clinical trials publications.
    Freeman WR
    Ophthalmology; 2005 Sep; 112(9):1485-6. PubMed ID: 16139664
    [No Abstract]   [Full Text] [Related]  

  • 5. [Independent clinical trials are imperative].
    Gøtzsche PC
    Ugeskr Laeger; 2005 Apr; 167(14):1491-4. PubMed ID: 15887740
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 7. Researchers' links with biomed industry lead to bias in clinical trials.
    Matthews R
    New Sci; 2003 Feb; 177(2380):8. PubMed ID: 14587489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physicians' participation in clinical drug trials].
    Nielsen OH; Ainsworth M
    Ugeskr Laeger; 2003 Apr; 165(16):1639. PubMed ID: 12756815
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials and public trust: the geographical shift to the Asia-Pacific region.
    Torralba KD; Khan NA; Quismorio FP
    Int J Rheum Dis; 2009 Sep; 12(3):186-91. PubMed ID: 20374345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes.
    Goldacre B
    BMJ; 2009 Nov; 339():b4949. PubMed ID: 19946143
    [No Abstract]   [Full Text] [Related]  

  • 11. [Constraints on publication rights in industry-initiated clinical trials--secondary publication].
    Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW
    Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Openness in the cooperation between physicians and private corporations].
    Jørgensen J; Djurhuus JC
    Ugeskr Laeger; 2003 Apr; 165(16):1642-5. PubMed ID: 12756817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical investigators and the pharmaceutical industry.
    Bellin E
    N Engl J Med; 2000 Aug; 343(7):511. PubMed ID: 10950676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does "commercial bias" exist?].
    Lindberg M
    Ugeskr Laeger; 2003 Sep; 165(37):3539-41; author reply 3541-3. PubMed ID: 14531359
    [No Abstract]   [Full Text] [Related]  

  • 15. [An ethical dilemma].
    Werkö L
    Lakartidningen; 2004 Aug; 101(32-33):2500. PubMed ID: 15346626
    [No Abstract]   [Full Text] [Related]  

  • 16. ["I accuse"].
    Sørensen TI
    Ugeskr Laeger; 2005 Apr; 167(14):1487. PubMed ID: 15887738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Researchers' statements concerning their economic liaisons].
    Kesek M
    Lakartidningen; 2002 May; 99(19):2191. PubMed ID: 12082940
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicians and drug industry].
    Hallager K
    Ugeskr Laeger; 2004 May; 166(21):2069. PubMed ID: 15222087
    [No Abstract]   [Full Text] [Related]  

  • 19. Conducting industry-partnered trials in orthopaedic surgery.
    Bhandari M; Jönsson A; Bühren V
    Injury; 2006 Apr; 37(4):361-6. PubMed ID: 16473356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vulnerability of radiation oncology within the medical industrial complex.
    Goffman TE; Glatstein E
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):1-3. PubMed ID: 15093891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.